Thérapie focale du cancer de la prostate : qui, quand, où et comment ? (notice n° 271774)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01742cam a2200277 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112080947.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Stelmes, Jean-Jacques |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Thérapie focale du cancer de la prostate : qui, quand, où et comment ? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2019.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 38 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméLa thérapie focale du cancer de la prostate est une stratégie de préservation d’organe qui s’est développée au cours des dernières années et qui connaît une popularité de plus en plus importante au sein de la communauté. Des arguments convaincants existent et des résultats prometteurs ont été obtenus en termes d’efficacité et de tolérance, et cela non seulement pour les cancers de la prostate à bas risque mais aussi pour ceux à risque intermédiaire. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Focal therapy for prostate cancer is an organ preservation strategy that has been developed in recent years and has gained popularity among the community. Increasing evidence is available and promising results in terms of efficacy and tolerance have been obtained, not only for low-risk but also for intermediate-risk prostate cancers. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | thérapie focale |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | bas risque et risque intermédiaire |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | préservation d’organe |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cancer de la prostate |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | low and intermediate risk |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | organ preservation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | focal therapy |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | prostate cancer |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Crouzet, Sébastien |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Innovations & Thérapeutiques en Oncologie | Volume 5 | 5 | 2019-09-01 | p. 283-286 | 2431-3203 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2019-5-page-283?lang=fr">https://shs.cairn.info/revue-innovations-et-therapeutiques-en-oncologie-2019-5-page-283?lang=fr</a> |
Pas d'exemplaire disponible.
Réseaux sociaux